US Patent Issued to Tianjin Institute of Pharmaceutical Research on March 25 for "Glucagon-derived peptide and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,287, issued on March 25, was assigned to Tianjin Institute of Pharmaceutical Research Co. Ltd. (Tianjin, China).

"Glucagon-derived peptide and use thereof" was invented by Yingmei Han (Tianjin, China), Wei Liu (Tianjin, China), Bingni Liu (Tianjin, China), Weiling Kong (Tianjin, China), Naxia Zhao (Tianjin, China), Guangping Xia (Tianjin, China), Qian Shang (Tianjin, China), Xiaohua Kong (Tianjin, China), Jing Jin (Tianjin, China), Yuquan Li (Tianjin, China) and Xuyuan Liu (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a polypeptide derivative, modified derivative or salt thereof, and use of the polypeptide derivative, ...